Cargando…
Examining the effects of uric acid-lowering on markers vascular of calcification and CKD-MBD; A post-hoc analysis of a randomized clinical trial
BACKGROUND: Chronic kidney disease (CKD)-mineral and bone disorder (MBD) is a systemic disorder that leads to vascular calcification and accelerated atherosclerosis. Uric acid has been shown to associate with vascular calcification and with carotid intima-media thickness (CIMT) and to suppress the 1...
Autores principales: | Andrews, Emily S., Perrenoud, Loni, Nowak, Kristen L., You, Zhiying, Pasch, Andreas, Chonchol, Michel, Kendrick, Jessica, Jalal, Diana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6200237/ https://www.ncbi.nlm.nih.gov/pubmed/30356327 http://dx.doi.org/10.1371/journal.pone.0205831 |
Ejemplares similares
-
Uric Acid Lowering and Biomarkers of Kidney Damage in CKD Stage 3: A Post Hoc Analysis of a Randomized Clinical Trial
por: Perrenoud, Loni, et al.
Publicado: (2020) -
Prevention and Treatment of CKD-MBD
por: Cozzolino, Mario
Publicado: (2013) -
CKD-MBD after kidney transplantation
por: Wesseling-Perry, Katherine, et al.
Publicado: (2011) -
A Japanese approach for CKD-MBD
por: Yokoyama, Keitaro, et al.
Publicado: (2013) -
The Role of Vitamin K in CKD-MBD
por: Fusaro, Maria, et al.
Publicado: (2022)